Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication

Table 3

Data of all patients with at least 10-year diabetes duration examined for the first time during the last 25 years but lost to follow-up after at least one-year regular visits.

𝑁	T2DM		T1DM
	950 (All)	CA + (𝑛=101)	102 (all)	CA + (𝑛=2)
		10.6%		2.0%
Sex (male)	545 (57.4%)	54 (54.5%)	61 (59.8%)
Age	67.9 ± 0.3	69.7 ± 0.9	41.6 ± 1.4	57.5 ± 9.5
Age of diabetes onset	50.2 ± 0.3	53.0 ± 1.1	21.7 ± 1.4	25.5 ± 7.5
Diabetes duration	18.0 ± 0.2	19.3 ± 0.9	19.9 ± 0.9	32.0 ± 2.0
OADs (%)	652 (68.6%)	63.4%
OADs + basal insulin	22 (2.3%)	1.0%
Insulin treated	276 (29.1%)	35.6%
Years of DM before insulin initiation	15.1 ± 0.4	13.9 ± 1.2
A1c	7.5 ± 0.0	7.2 ± 0.1	8.4 ± 0.2	6.5 ± 1.2
BMI	27.9 ± 0.1	28.0 ± 0.5	25.5 ± 0.4	22.6 ± 0.0

OADs: oral antidiabetic drugs.